Generation and Function of NK Cell Memory

NK细胞记忆的产生和功能

• 批准号: 8701645
• 负责人: ULRICH H VON ANDRIAN
• 金额: $ 78.47万
• 依托单位: HARVARD MEDICAL SCHOOL
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-08-15 至 2018-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8701645
• 关键词: AIDS/HIV problem; Acute; Address; Affinity; Anatomy; Animal Model; Animals; Antibodies; Antigen-Presenting Cells; Antigens; Antiviral Agents; B-Cell Activation; B-Lymphocytes; Behavior; Binding; Biological Models; Blood Circulation; Blood Vessels; Blood flow; Bone Marrow; CD4 Positive T Lymphocytes; Cell Communication; Cell physiology; Cells; Characteristics; Chronic; Clinical; Collaborations; Complement; Complement 3d Receptors; Complement Receptor; Consequences of HIV; Coupling; Data; Dendritic Cells; Deposition; Development; Disease; Drainage procedure; ERBB2 gene; Effectiveness; Event; Exposure to; Floor; Follicular Dendritic Cells; Functional disorder; Gatekeeping; Generations; HIV; HIV Antigens; HIV Infections; Helper-Inducer T-Lymphocyte; Hematopoietic; Host Defense; Human; Humoral Immunities; Image; Imagery; Immune; Immune response; Immune system; Immunity; Immunization; Immunoglobulin Class Switching; Immunologic Memory; Immunologist; Individual; Infection; Inflammatory; Influenza; Injection of therapeutic agent; Intervention; Investigation; Knowledge; Lead; Learning; Left; Life; Liquid substance; Lymph; Lymph Node Subcapsular Sinus; Lymphatic; Lymphatic System; Lymphocyte; Lymphocytic choriomeningitis virus; Mammals; Memory; Memory B-Lymphocyte; Microbe; Mind; Modeling; Monoclonal Antibodies; Mouse Strains; Mucous Membrane; Mus; Mutation; Myelogenous; Natural Immunity; Natural Killer Cells; Organ; Outcome; Pan Genus; Pathogenesis; Pathway interactions; Peripheral; Phagocytes; Phase; Phenotype; Physiological; Plant Roots; Play; Positioning Attribute; Prevention; Process; Proteins; Reaction; Receptor Signaling; Recording of previous events; Regulation; Relative (related person); Resistance; Reticular Cell; Role; Route; Series; Simplexvirus; Sinus; Site; Skin; Source; Stem cells; Stream; Streptococcus pneumoniae; Structure of germinal center of lymph node; Structure of subclavian vein; Surface; System; T cell response; T-Lymphocyte; Testing; Thoracic Duct; Time; Tissues; Travel; Vaccines; Vesicular stomatitis Indiana virus; Viral; Viral Antigens; Viral Vaccines; Virion; Virus; Virus Diseases; Work; adaptive immunity; antigen challenge; base; capsule; cell motility; complement pathway; complement system; cytokine; evidence base; exhaust; improved; in vivo; influenzavirus; insight; intravital microscopy; lymph nodes; macrophage; microbial; mouse model; multi-photon; nanoparticle; new therapeutic target; novel therapeutics; particle; pathogen; prevent; programs; prophylactic; receptor; research study; response; stem; tool; vaccine development

This Program entitled "Anti-viral Immune Responses in Lymph Nodes", seeks to gain a deeper understanding of the induction and regulation of immunological events that are elicited by viral antigens in lymph nodes (LNs). Many viruses and most conventional vaccines enter the body through the skin and travel via lymphatics to draining LNs. These organs are believed to have a critical role in the adaptive immune response to peripheral infections; therefore, understanding the cellular and molecular interactions that occur within LNs will provide insights that may be useful for improved vaccine development. Lymph-borne foreign matter entering LNs is captured and processed by antigen-presenting cells (APCs), which then present this material to B and T cells to elicit effector responses and long-lived immunological memory. The rules that determine how lymph-derived antigenic material is handled in LNs, especially in the context of ongoing infections, and what cells and molecules must interact to elicit a protective immune response (or fail to do so) are poorly understood. Why do some viruses (e.g. VSV in mice) induce a potent, multi-pronged protective immune response that eliminates the pathogen, while others (e.g. influenza) generate only transient protective immunity, and a few (e.g. HIV in humans) establish a chronic presence by continuously subverting and eventually exhausting the host's anti-viral defenses? The mechanisms behind these different outcomes are likely multi-factorial and depend upon differences in the way individual viruses interact with their hosts. To explore the dynamics of these interactions in living animals, all component projects of this Program will employ multi-photon intravital microscopy (MP-IVM) in intact LNs that will be offered in the Intravital Microscopy Core for time-and space-resolved visualization of the innate and adaptive immune response to lymph-borne virions. In Project 1, Dr. von Andrian will explore innate and adaptive immune responses to lymph-borne viral infections using VSV and several other viral pathogens. In Project 2. Drs. Sharpe and Wherry will visualize the effects of the negative costimulatory pathways, PD-1:PD-L1, PD-1:PD-L2 and PDL1 :B7.1 on antiviral immunity to influenza and LCMV. In Project 3. Dr. Carroll will dissect the role of complement and complement receptors in humoral immunity to influenza virus. Finally, in Project 4, Drs. Luster. Mempel and Taqer will characterize the cellular dynamics and viral dissemination in HIV-infected lymph nodes of humanized mice. It is hoped that the mechanistic insights gained from these highly interactive and synergistic experiments will lead to new, evidence-based and knowledge-driven development strategies for anti-viral vaccines.

这项名为“淋巴中的抗病毒免疫反应”的计划，旨在获得更深层次的 对病毒抗原诱导和调节免疫事件的了解 淋巴结(LNS)。许多病毒和大多数传统疫苗通过皮肤进入人体并传播 通过淋巴管引流淋巴管。这些器官被认为在获得性免疫中起着关键作用。 对外周感染的反应；因此，了解发生的细胞和分子相互作用 LNS将提供可能对改进疫苗开发有用的见解。淋巴传播的异物 进入LNS的物质被抗原提呈细胞(APC)捕获和处理，然后将 材料B和T细胞，以激发效应器反应和长寿免疫记忆。这些规则是 确定淋巴来源的抗原材料在LNS中如何处理，特别是在正在进行的情况下 感染，以及哪些细胞和分子必须相互作用才能引起保护性免疫反应(或无法做到) 人们对此了解甚少。为什么一些病毒(例如小鼠的VSV)会诱导一种强大的、多管齐下的保护性 消除病原体的免疫反应，而其他免疫反应(如流感)仅产生短暂的 保护性免疫，少数(例如人类中的艾滋病毒)通过不断颠覆 并最终耗尽宿主的抗病毒防御能力？这些不同结果背后的机制 可能是多因素的，取决于单个病毒与宿主相互作用的方式的差异。 为了探索活体动物中这些相互作用的动态，该计划的所有组成部分项目将 使用多光子活体内显微镜(MP-IVM)检查将在活体内提供的完整的LNS 用于时间和空间分辨率可视化的显微核心的先天和获得性免疫反应 淋巴传播的病毒粒子。在项目1中，冯·安德里安博士将探索先天和获得性免疫反应 使用VSV和其他几种病毒病原体的淋巴传播病毒感染。在项目2中，夏普博士和 Wherry将可视化负共刺激通路的影响，PD-1：PD-L1，PD-1：PD-L2和PDL1 ：B7.1关于对流感和LCMV的抗病毒免疫。在项目3中，卡罗尔博士将剖析 流感病毒体液免疫中的补体和补体受体最后，在项目4中，Dr。 光彩照人。Mempel和Taqer将描述HIV感染者的细胞动力学和病毒传播 人源化小鼠的淋巴结。希望从这些高度机械的洞察力中获得 互动和协同实验将带来新的、以证据为基础和知识驱动的发展 抗病毒疫苗的战略。